Bell’s palsy: A Neurological Manifestation of COVID-19
Infection
Corresponding author: Amro Abdelrahman
Department: Medical Education, Hamad Medical Corporation, Doha, Qatar.
E-mail: Amrxmd@gmail.com
Abstract :
Bell’s palsy is an acute peripheral facial paralysis commonly associated
with viral infections. COVID-19 may be a potential cause of peripheral
facial paralysis and other neurological manifestations.
We report a case of Bell’s palsy due to COVID-19 infection in a
previously healthy 35 -year- old male
Case presentation :
A 35-year-old male with no past medical history presented to the
emergency department complaining of a 2- day history of sudden
right-sided facial weakness associated with fever, cough, and sore
throat. Three days ago, the patient went to a primary health care center
due to upper respiratory tract symptoms, and a diagnosis of covid-19
infection was made.
Two days later, the patient suddenly developed weakness associated with
numbness, drooling saliva while eating and difficulty closing the right
eye. He had no other neurologic symptoms and denied ear pain, skin rash,
or arthralgia. He has no past medical history, a recent history of
travel, or a tick bite. A systematic review was unremarkable.
In the ED, his vital signs were within normal limits. Physical
examination revealed the absence of right-sided forehead wrinkles
compared to the left, drooping of the right eyelid, and prominent mouth
deviation suggestive of right lower motor neuron facial nerve palsy.
Careful examination of ears showed dry impacted wax in the right ear
with no vesicles. Examination of the parotid gland was unremarkable.
Sensation in both upper and lower extremities was intact. No weakness
was noted in either the upper or lower limbs. Kernig’s and Brudzinski’s
signs were negative. Examination of other systems was unremarkable.
The patient’s complete blood count and basic metabolic panel were within
normal ranges. His COVID-19 rapid antigen test was positive. Chest x-ray
was unremarkable. A diagnosis of Bell’s palsy secondary to COVID-19
infection was made, and the patient was treated with prednisolone,
levocetirizine, gentamicin, paracetamol, and eye drops. He was also
referred to a physical therapy clinic. On his four-week follow-up visit,
the patient showed no significant improvement.
Introduction :
COVID -19 infection has affected millions of people worldwide. It’s an
infectious disease caused by the SARS-CoV-2 virus. People with COVID -19
infection have had a wide range of symptoms reported ranging from a mild
cough to acute respiratory syndrome
(ARDS).[1] These
patients’ common complications and causes of death include sepsis, acute
kidney injury, ARDS, acute hypoxic encephalopathy, and acute cardiac
injury.[1]
Expanding number of COVID-19 associated with facial nerve palsies are
now being reported, with most being the first presenting symptom or
occurring within the first week of onset of viral symptoms or a positive
COVID-19 test.[2]
Other neurological complications such as anosmia, dysgeusia,
encephalopathy, Guillain-Barre syndrome, Miller-Fisher syndrome, and
polyneuritis cranialis may also
present.[3]
Discussion :
Besides the usual and well-known respiratory symptoms, the SARS-CoV-2
virus can affect the peripheral and central nervous systems.
Neurological symptoms can be the first manifestation of COVID-19
infection or concurrent respiratory symptoms. A retrospective review
reported neurological symptoms in 36.5% of patients.[4]
Two different mechanisms could explain the neuropathogenesis of
SARS-CoV-2 virus. The first mechanism is due to endothelial damage and
the subsequent passing of the virus from the systemic circulation to the
cerebral circulation. The alternative mechanism is thought to be due to
the direct entering of the virus through the cribriform wall and
olfactory bulb, where the olfactory nerve
terminates.[5]
Using the olfactory pathways, the virus can harm the central nervous
system (CNS), which may propagate from neuron to neuron by axonal
transport.[6]
When glial cells get infected with the virus, the body enters a
pro-inflammatory state and releases cytokines. The prolonged exposure to
cytokines may lead to nerve damage.[7]
Moreover, various types of neurological manifestations of COVID-19
infection have been reported. For example, Filatov et al. reported a
case of encephalopathy following COVID-19 illness on the same day of
admission.[8]
A case series from Spain described cranial nerve manifestations
associated with COVID-19 disease in two patients, one of which developed
Miller Fisher syndrome on day five and the other developed polyneuritis
cranialis on day three.[9]
A previous study also described a case of an isolated facial paralysis
presented after six days in a patient with COVID-19 infection.[2]
Our patient experienced a lower motor neuron facial paralysis on the 3rd
day of his ongoing COVID-19 infection.
Bell’s palsy is a lower motor neuron impairment of the facial cranial
nerve, manifesting acutely as a unilateral facial
paralysis.[10]
Although the reason for many cases is unidentifiable, the most common
cause of peripheral facial palsy is attributed to infections, mainly
HSV-1, VZV, and Lyme
disease.[11] Our
patient denied any recent travel, trauma, insect bite, skin rash, joint
pain, itchiness, or tingling sensation in the body. Physical examination
was unremarkable, with no skin rash; the outer ear canal was clear, and
no signs of meningitis. Causes such as autoimmune and vasculitis were
excluded as the patient did not
have any systemic findings; HIV infection was also excluded as it is a
part of the infectious screening for all people getting their
residencies in the country. The patient had a fever, sore throat, and
generalized body pain, and his COVID-19 rapid antigen test came
positive. Therefore, no other etiologies than COVID-19 infection could
be attributed to palsy.
COVID-19 infection is known to present mainly as respiratory symptoms
ranging from mild to severe, such as acute respiratory distress syndrome
(ARDS) and
fever.[12] In
addition, neurological manifestations, including Guillain-Barre
syndrome, Anosmia/ageusia, encephalopathy, and myelitis, are also
encountered.[11]
Bell’s palsy has been one of COVID-19’s manifestations. Poor prognosis
is predicted in patients > 60 years of age with systemic
problems such as diabetes mellitus, severe pain in the ear, and loss of
tears. Bell’s palsy generally has a good prognosis and recovery of
90%.[13]
Regarding the treatment, the most used one in facial paralysis is
corticosteroids, with high effectiveness
rates.[12]
Prednisolone’s effect on the facial nerve is by reducing its
edema.[14] In our
case, the patient had no risk factors for poor prognosis; he was
prescribed prednisolone 20mg for ten days and referred to a
physiotherapy clinic. His four-week follow-up visit showed no
significant change in his condition.